Remedy Robotics raises A$92m Series B, no sales team yet
San Francisco medtech Remedy Robotics closed US$62 million (A$92m) Series B for remote stroke surgery tech. Perth-born cofounder David Bell is funding clinical trials and FDA approval. Worth noting: they are pre-revenue, pre-approval, and not hiring commercial roles. This is R&D capital, not go-to-market money.